The following investment analysts currently provide research on ReNeuron:

1. Analyst                          Broker                        Recommendation         Price Target

Navid Malik                    Cenkos Securities      Buy                                  22p

Robin Campbell             Merchant Securities   Buy                                   33p

Please click on link below for webcast of presentation by Michael Hunt, CEO at the 2011 Stem Cell on the Mesa Conference, La Jolla, CA, USA on 1st December 2011

http://app.wistia.com/embed/medias/e9611ffada?width=640&height=360&autoplay=false&playbutton=true&controls_visible=true&end_video_behavior

Please click on link below for webcast of 2011 Interim Results presentation to analysts.

http://media.buchanan.uk.com/reneuron281111/index.html

Please click on link below for CNBC interview with Vadim Alexandre, Healthcare Analyst, Daniel Stewart

Updated research notes can be obtained via the following link:

http://www.cenkos.com/pages/services/corporateFinance.aspx